UNSPSC 51312203: Desloratadine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FVF865388R, chemically known as 5h-benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)- but generally known as desloratadine, which bears US NIH Compound Identifier 124087. European Medicines Agency schedules Desloratadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01596MIG.

UNSPSC 51312203 Desloratadine is a Commodity code nominally covering a specific antihistamine drug product, but recent state and local solicitations tagged under this code do not reflect procurement of desloratadine itself; instead, they capture broader pharmaceutical supply, naloxone distribution, and direct-to-manufacturer prescription program initiatives that fall outside the code's stated scope. The mismatch between the code name and the actual work being solicited suggests this code sees limited relevant recent activity for desloratadine-specific procurement.

Recent opportunities under this code include a Seminole County, Florida IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems; a Texas Health and Human Services Commission RFI (HHS0017013, issued April 3, 2026) exploring direct-to-manufacturer prescription contracting; and a Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson. The Minnesota solicitation is the most recent and largest in scope, serving state and local government facilities across multiple jurisdictions including Oregon, with weighted evaluation favoring price competitiveness at 75 percent and requiring cGMP and DSCSA compliance. Florida and Texas show activity, but the records do not support desloratadine as a targeted procurement line item in any of these solicitations. Firms evaluating this code should verify whether desloratadine-specific demand exists separately from these broader pharmaceutical-supply and distribution initiatives, as the current tagging appears misaligned with actual procurement intent.